NYSE:PRT - PermRock Royalty Trust Stock Price, Forecast & News

PermRock Royalty Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRT."

PermRock Royalty Trust announced a monthly dividend on Friday, December 20th. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.051 per share on Wednesday, January 15th. This represents a $0.61 annualized dividend and a yield of 10.02%. The ex-dividend date of this dividend is Monday, December 30th. This is a positive change from PermRock Royalty Trust's previous monthly dividend of $0.04. View PermRock Royalty Trust's Dividend History.

PermRock Royalty Trust (NYSE:PRT) announced its quarterly earnings results on Thursday, November, 14th. The company reported $0.21 EPS for the quarter. The business had revenue of $7.65 million for the quarter. View PermRock Royalty Trust's Earnings History.

PermRock Royalty Trust is scheduled to release their next quarterly earnings announcement on Monday, April 6th 2020. View Earnings Estimates for PermRock Royalty Trust.

Headlines about PRT stock have trended positive recently, according to InfoTrie Sentiment. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. PermRock Royalty Trust earned a daily sentiment score of 3.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for PermRock Royalty Trust.

PermRock Royalty Trust saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 41,200 shares, an increase of 34.6% from the December 15th total of 30,600 shares. Based on an average trading volume of 67,800 shares, the days-to-cover ratio is currently 0.6 days. Currently, 0.7% of the shares of the stock are sold short. View PermRock Royalty Trust's Current Options Chain.

Some companies that are related to PermRock Royalty Trust include HighPoint Resources (HPR), Amplify Energy (AMPY), Extraction Oil & Gas (XOG), Roan Resources (ROAN), TETRA Technologies (TTI), Montage Resources (MR), VAALCO Energy (EGY), Panhandle Oil and Gas (PHX), SandRidge Energy (SD), TransGlobe Energy (TGA), SilverBow Resources (SBOW), Painted Pony Energy (PDPYF), Epsilon Energy (EPSN), VOC Energy Trust (VOC) and MV Oil Trust (MVO).

Based on aggregate information from My MarketBeat watchlists, some companies that other PermRock Royalty Trust investors own include New Residential Investment (NRZ), Main Street Capital (MAIN), Apple Hospitality REIT (APLE), Golar LNG Partners (GMLP), Hercules Capital (HTGC), Starwood Property Trust (STWD), InfraCap MLP ETF (AMZA), AbbVie (ABBV), Energy Transfer LP Unit (ET) and Macquarie Infrastructure (MIC).

(PRT) raised $126 million in an initial public offering (IPO) on Wednesday, May 2nd 2018. The company issued 6,300,000 shares at a price of $19.00-$21.00 per share. Wells Fargo Securities, Goldman Sachs, UBS Investment Bank, Deutsche Bank Securities, Jefferies, Stifel and Oppenheimer served as the underwriters for the IPO and BB&T Capital Markets and Janney Montgomery Scott were co-managers.

Shares of PRT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of PRT stock can currently be purchased for approximately $6.11.

PermRock Royalty Trust has a market capitalization of $74.36 million and generates $16.24 million in revenue each year. View Additional Information About PermRock Royalty Trust.

The official website for PermRock Royalty Trust is http://www.permrock.com/.

PermRock Royalty Trust's mailing address is P.O. Box 470727, FORT WORTH TX, 76147. The company can be reached via phone at 855-588-7839.